Newsletter Subject

⚡Stocks should be falling right now

From

riskhedge.com

Email Address

subscribers@riskhedge.com

Sent On

Fri, Feb 23, 2024 04:07 PM

Email Preheader Text

A pullback would be perfectly normal for this time of year… Stocks should be falling right now

A pullback would be perfectly normal for this time of year… [The Jolt with Stephen McBride] Stocks should be falling right now Nvidia (NVDA) knocked it out of the park with earnings on Wednesday, again. It was the most impressive quarter I’ve seen from any company, ever. Revenues jumped 265% over the past year, while artificial intelligence (AI)-related revenues quintupled! Anyone who runs a business knows how hard it is to double sales in a year. Nvidia is growing like a nimble startup, but at a multibillion-dollar scale. I still think it could become the world’s most valuable company before the AI boom is over. At the start of February, I warned a [stock market correction was likely looming](. Yet the S&P 500 made a new record high yesterday, fueled by Nvidia. Here’s what to do… - You should expect stocks to be falling right now. We’re in February in a presidential election year, so it’s perfectly normal for markets to pull back here. Look at the dark blue line (election years) in this chart. Markets typically surge out of the gate, then dip right around now: Source: Goldman Sachs February is historically the second-worst month for stocks. The fact that the S&P 500 is bucking these trends and has kept making new all-time highs is important information. It tells us this market has real momentum behind it, and it’s stronger than anyone believes. So where do markets go from here? I still expect a pullback. Although the S&P 500 has historically been up three out of every four years since 1980… the average yearly sell-off is 14%. Lesson: Expect the market to drop around 15% at least once a year. And as the above chart shows, stocks typically have a weak first half and a strong second half in presidential election years. Don’t be surprised if the S&P 500 trades sideways until the summer, or even until November. - Are you invested in the biotech revolution? Back in 2011, early Facebook (META) employee Jeff Hammerbacher told Bloomberg: “The best minds of my generation are thinking about how to make people click ads… that sucks.” I agree… and I regret that we’ve been in [a mini “dark age” for innovation over the past 15 years](. Our brightest kids snagged cushy jobs in Silicon Valley and spent their days gamifying apps and optimizing digital ads. What a waste of talent. Imagine if instead they chose to build next-gen nuclear reactors… or develop lifesaving drugs? Well, better late than never. Scientists are developing ways to “delete” diseases from our bodies. Gene editing allows doctors to “cut” out bad genes that cause disease and replace them with healthy genes. The first-ever gene editing therapy was approved in America and the UK late last year. And now, a group of Harvard Medical School doctors have used gene therapy to give hearing to five deaf children. This treatment has the potential to transform the lives of some 30 million kids who were born deaf. Scientists are also on the cusp of achieving a holy grail: blood tests that can detect Alzheimer’s at a very early, pre-symptomatic stage. Researchers in the UK built a ChatGPT-like AI model to sift through 1,500 blood markers. They were able to predict Alzheimer’s with 90% accuracy… nearly 15 years before people were diagnosed… all with a routine blood test. By the time we catch Alzheimer’s today, it’s almost always too late. Early detection means patients could be treated with the first Alzheimer’s drug approved by the FDA last year. It’s such a shame there are still thousands of uncurable diseases. A mechanic can pinpoint and fix almost any problem with your car instantly. Our bodies are infinitely more complex than a Toyota… but I know we can do a lot better. We’ve barely scratched the surface of what’s possible when it comes to curing disease and longevity. I’m confident this biotech revolution will lead to some incredible breakthroughs. Chris Wood and I recently added one of the world’s best biotech companies to the [Disruption Investor]( portfolio. - Today’s dose of optimism… Elon Musk’s SpaceX built the largest and most powerful rocket ever—the 400-ft. Starship—which is designed to get us to Mars. Elon recently tweeted this picture of Starship’s Super Heavy rocket booster: Source: @elonmusk on X I’m a sucker for man-made beauty, and this is a gem. Fully grown men look like tiny ants next to it. While “decelerationists” in San Francisco recently [set fire to a Waymo robo-taxi](, the good guys are trying to get us to the stars. Yesterday, SpaceX’s Falcon 9 rocket—carrying a cargo lander named “Odysseus”—became the first American spacecraft to land on the moon’s surface since 1972. And Mars-bound Starship is preparing for its third test flight in a couple weeks. SpaceX is among the most valuable private companies, valued at $175 billion. It’s the best illustration of [America waking up from its innovation slumber](. The 2010s were all about building cool apps. Yawn. Now we’re launching 400 ft. rockets into outer space… which gently touch down on a landing pad once the mission is complete. Imagine the engineering chops it took to achieve this? I can feel the innovation shift in my bones. A new tech frontier is opening up. Get ready for [energy too cheap to meter](… the ability to delete diseases… personalized AI assistants… and Mars-bound rocket ships. If you can’t tell, I’m fired up for the near future. Have a great weekend. I’ll see you Monday. Stephen McBride Chief Analyst, RiskHedge Suggested Reading... [Start investing with Stephen](  [A unique way to profit off AI...]( If someone forwarded you this email and you would like to be added to our email list to receive the Jolt every week, [simply sign up here.]( This email was sent to {EMAIL} as part of your subscription to The Jolt. To opt-out, please visit the [unsubscribe page](. [READ IMPORTANT DISCLOSURES HERE.]( YOUR USE OF THESE MATERIALS IS SUBJECT TO THE TERMS OF THESE DISCLOSURES. Copyright © 2024 RiskHedge. All Rights Reserved RiskHedge | 1417 Sadler Road, PMB 415 | Fernandina Beach, FL 32034

Marketing emails from riskhedge.com

View More
Sent On

31/05/2024

Sent On

29/05/2024

Sent On

28/05/2024

Sent On

27/05/2024

Sent On

24/05/2024

Sent On

22/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.